A. Gottlieb

949 total citations
11 papers, 451 citations indexed

About

A. Gottlieb is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, A. Gottlieb has authored 11 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 3 papers in Genetics. Recurrent topics in A. Gottlieb's work include Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). A. Gottlieb is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). A. Gottlieb collaborates with scholars based in United States. A. Gottlieb's co-authors include N I Nissen, Leon Stutzman, Glicksman As, Cooper Mr, Jack Goldberg, Hans Grünwald, George P. Browman, Azra Raza, Harvey D. Preisler and Richard A. Larson and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and British Journal of Haematology.

In The Last Decade

A. Gottlieb

11 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Gottlieb United States 9 231 162 143 109 101 11 451
Cooper Mr United States 10 161 0.7× 97 0.6× 230 1.6× 115 1.1× 160 1.6× 27 494
F. B. Hagemeister United States 10 329 1.4× 304 1.9× 56 0.4× 68 0.6× 45 0.4× 25 564
Marzia Salvucci Italy 15 214 0.9× 321 2.0× 289 2.0× 90 0.8× 146 1.4× 27 716
R Battista Italy 14 141 0.6× 142 0.9× 278 1.9× 91 0.8× 282 2.8× 42 581
C Skosey United States 7 241 1.0× 55 0.3× 206 1.4× 209 1.9× 152 1.5× 7 623
Marino Brunori Italy 16 334 1.4× 90 0.6× 416 2.9× 205 1.9× 57 0.6× 30 649
Riccardo Centurioni Italy 15 236 1.0× 67 0.4× 457 3.2× 156 1.4× 95 0.9× 40 685
J. Lim United Kingdom 9 122 0.5× 192 1.2× 112 0.8× 36 0.3× 80 0.8× 13 340
Bungo Saito Japan 14 164 0.7× 102 0.6× 205 1.4× 76 0.7× 56 0.6× 47 485
Agustin Avilés Mexico 10 525 2.3× 97 0.6× 96 0.7× 65 0.6× 224 2.2× 21 733

Countries citing papers authored by A. Gottlieb

Since Specialization
Citations

This map shows the geographic impact of A. Gottlieb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gottlieb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gottlieb more than expected).

Fields of papers citing papers by A. Gottlieb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gottlieb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gottlieb. The network helps show where A. Gottlieb may publish in the future.

Co-authorship network of co-authors of A. Gottlieb

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gottlieb. A scholar is included among the top collaborators of A. Gottlieb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gottlieb. A. Gottlieb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Glicksman, Arvin S., Bruce E. Peterson, N I Nissen, et al.. (1996). 24 Augmented therapy of extensive Hodgkin's disease: Radiation to bulk disease or prolongation of induction chemotherapy did not improve survival. International Journal of Radiation Oncology*Biology*Physics. 36(1). 170–170. 1 indexed citations
2.
Luzzani, Massimo, et al.. (1990). Disodium clodronate in the treatment of pain due to bone metastases.. PubMed. 10(4). 243–6. 6 indexed citations
3.
Sato, Hiroshi, Harvey D. Preisler, Roger Day, et al.. (1990). MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. British Journal of Haematology. 75(3). 340–345. 157 indexed citations
4.
Raza, Azra, Yogesh Maheshwari, Zahida Yasin, et al.. (1987). Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia.. PubMed. 14(2 Suppl 1). 217–25. 14 indexed citations
5.
Brownell, Kelly D., Thomas J. Glynn, Russell E. Glasgow, et al.. (1986). Interventions to prevent relapse.. PubMed. 5 Suppl. 53–68. 15 indexed citations
6.
Gp, Canellos, et al.. (1985). Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171.. PubMed. 69(6). 719–20. 9 indexed citations
7.
Pajak, Thomas F., A. Gottlieb, Arvin S. Glicksman, et al.. (1984). The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.. Journal of Clinical Oncology. 2(7). 748–755. 22 indexed citations
8.
As, Glicksman, et al.. (1982). Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.. PubMed. 66(4). 1035–44. 124 indexed citations
9.
Peterson, B. A., Thomas F. Pajak, M. R. Cooper, et al.. (1982). Effect of age on therapeutic response and survival in advanced Hodgkin's disease.. PubMed. 66(4). 889–98. 67 indexed citations
10.
11.
Ginsberg, Sandra J., A. Gottlieb, Jack Goldberg, et al.. (1979). Long-term survivorship in small-cell anaplastic lung carcinoma.. PubMed. 63(8). 1347–9. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026